Active Research Protocols
- 01-H-0162 – Ex Vivo Selective Depletion of Alloreactive Donor T-Lymphocytes Using RFT5-SMPT-dgA, a Specific Anti-Interleukin-2 Receptor Immunotoxin: Reducing GVHD Risk Associated with HLA-Matched, Nonmyeloablative, Peripheral Blood Stem Cell Transplantation for Hemat
- 06-C-0227 – Phase I Trial of Intravenous Fenretinide (4-HPR) for Patients with Hematologic Malignancies
- 97-H-0202 – Low Intensity Preparative Regimen Followed by HLA-Matched, Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in Older Adults
NOTE: PDF documents require the freeAdobe Reader.
This page was last updated: January 24, 2014